CURIS INC (CRIS)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Between 2026-08-02 and 2026-10-31, public records show 1 signal for CURIS INC. Most notable: 2026-10-19: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-10-31 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing acquisition or disposition of assets
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | KAITIN KENNETH I | director | P | 10,000 | 0.55 | $5,500 |
| 2026-03-20 | Zung Jonathan B. | officer | C | 66,667 | — | — |
| 2026-03-20 | Hamdy Ahmed MD | officer | C | 66,667 | — | — |
| 2026-03-20 | Duvall Diantha | officer | C | 66,666 | — | — |
| 2026-03-20 | Dentzer James E | director | C | 133,333 | — | — |
| 2026-03-20 | Rubin Marc | director | C | 26,667 | — | — |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.